Related Experiment Video
Updated: Jun 7, 2026

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
Implanted neurosphere-derived precursors promote recovery after neonatal excitotoxic brain injury
Luigi Titomanlio1, Myriam Bouslama, Virginia Le Verche
1Inserm, U676, Hopital Robert Debré, Paris, France.
Insights
Neural stem cell therapy shows promise for treating infant brain damage from excitotoxicity, a cause of cerebral palsy. Early implantation reduced lesion size and improved memory in neonatal mice, suggesting a potential future treatment.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Neonatal Neurology
Background:
- Excitotoxic brain damage is a primary cause of cerebral palsy in infants, leading to lifelong neurological deficits.
- Current therapeutic options for neonatal excitotoxic brain injury are limited.
- Neural stem cell therapy has shown potential in animal models but requires further investigation in neonates.
Purpose of the Study:
- To evaluate the efficacy of neural stem cell therapy in a neonatal mouse model of excitotoxic brain injury.
- To assess the survival, migration, and differentiation of implanted neurosphere-derived precursors.
- To determine the impact of cell therapy on lesion size and behavioral outcomes in neonates.
Main Methods:
- A neonatal mouse model of cerebral palsy was induced using ibotenate treatment on postnatal day 5.
- Neurosphere-derived precursors or fibroblasts were implanted into injured and control brains.
- Cell fate was tracked via immunohistochemistry; behavioral tests assessed functional recovery after early or late implantation.
Main Results:
- Implanted neurosphere-derived precursors migrated to the lesion site, remaining undifferentiated initially and differentiating into oligodendrocytes and neurons later.
- Despite eventual cell death, cell therapy significantly reduced lesion size and improved memory performance compared to controls.
- Both early and late implantation showed therapeutic benefits in the neonatal mouse model.
Conclusions:
- Cell therapy using neurosphere-derived precursors is a potential therapeutic strategy for acute excitotoxic brain injury in neonates.
- The procedure triggered endogenous repair mechanisms, leading to reduced brain damage and improved cognitive function.
- Further research is warranted to optimize cell therapy for clinical application in neonates.
Abstract:
Brain damage through excitotoxic mechanisms is a major cause of cerebral palsy in infants. This phenomenon usually occurs during the fetal period in human, and often leads to lifelong neurological morbidity with cognitive and sensorimotor impairment. However, there is currently no effective therapy. Significant recovery of brain function through neural stem cell implantation has been shown in several animal models of brain damage, but remains to be investigated in detail in neonates. In the present study, we evaluated the effect of cell therapy in a well-established neonatal mouse model of cerebral palsy induced by excitotoxicity (ibotenate treatment on postnatal day 5). Neurosphere-derived precursors or control cells (fibroblasts) were implanted into injured and control brains contralateral to the site of injury, and the fate of implanted cells was monitored by immunohistochemistry. Behavioral tests were performed in animals that received early (4 h after injury) or late (72 h after injury) cell implants. We show that neurosphere-derived precursors implanted into the injured brains of 5-day-old pups migrated to the lesion site, remained undifferentiated at day 10, and differentiated into oligodendrocyte and neurons at day 42. Although grafted cells finally die there few weeks later, this procedure triggered a reduction in lesion size and an improvement in memory performance compared with untreated animals, both 2 and 5 weeks after treatment. Although further studies are warranted, cell therapy could be a future therapeutic strategy for neonates with acute excitotoxic brain injury.

